Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.

Sponsor
Medical University of Bialystok (Other)
Overall Status
Recruiting
CT.gov ID
NCT05353413
Collaborator
University of Bialystok (Other)
20
1
2
48
0.4

Study Details

Study Description

Brief Summary

The aim of the project is to create a new, non-invasive and safe protocol for the early diagnosis of various types of optic neuropathies with the use of diffusion magnetic resonance imaging

Condition or Disease Intervention/Treatment Phase
  • Device: Neuroimaging
  • Diagnostic Test: VEP - visual evoked potential
  • Diagnostic Test: Ophthalmology examination.
N/A

Detailed Description

In this study, it is planned to find twenty volunteers for each of the neuropathies and twenty healthy volunteers. Each volunteer will undergo clinical tests such as visual acuity, color vision, intraocular pressure measurement, assessment of the anterior chamber and fundus using a slit lamp and Volk lens, macular optical coherence tomography examination and examination of the optic nerve disc (OCT), neurological field vision and visual evoked potential (VEP) testing. Each of the volunteers will undergo magnetic resonance imaging. During active scanning, patients will be asked for not blinking or moving their heads by staring at the red dot on the outside of the camera reflected in the coil mirror. The obtained diffusion tensor data will be used for further analysis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Two groups: volunteers with neuropathies and healthy volunteersTwo groups: volunteers with neuropathies and healthy volunteers
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.
Actual Study Start Date :
Jan 1, 2020
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Various types of optic neuropathies

Patients with various types of optic neuropathy.

Device: Neuroimaging
Magnetic resonance diffusion tensor imaging of the brain

Diagnostic Test: VEP - visual evoked potential
Electrophysiology of the visual pathway.

Diagnostic Test: Ophthalmology examination.
Full ophthalmological examination (visual acuity, color vision, measurement of intraocular pressure, evaluation of the anterior chamber and the fundus of the eye using a slit lamp and the Volk lens, optical coherence tomography examination of the macula and optic nerve disc (OCT), neurological field vision)

Other: Healthy volunteers

Healthy volunteers

Device: Neuroimaging
Magnetic resonance diffusion tensor imaging of the brain

Diagnostic Test: VEP - visual evoked potential
Electrophysiology of the visual pathway.

Diagnostic Test: Ophthalmology examination.
Full ophthalmological examination (visual acuity, color vision, measurement of intraocular pressure, evaluation of the anterior chamber and the fundus of the eye using a slit lamp and the Volk lens, optical coherence tomography examination of the macula and optic nerve disc (OCT), neurological field vision)

Outcome Measures

Primary Outcome Measures

  1. sigma parameter [one month]

    sigma parameter in our algorithm provides a quantitative measure of nerve atrophy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Optic neuropathy.

Exclusion Criteria:

common contraindications to MRI (presence of pacemaker, non-MRI-safety or claustrophobia)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lisowski Wasilkow Poland 16010

Sponsors and Collaborators

  • Medical University of Bialystok
  • University of Bialystok

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medical University of Bialystok
ClinicalTrials.gov Identifier:
NCT05353413
Other Study ID Numbers:
  • R-I-002/477/2019
First Posted:
Apr 29, 2022
Last Update Posted:
Apr 29, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Medical University of Bialystok
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 29, 2022